Identification and characterization of novel lipophilic antimicrobial peptides derived from naturally occurring proteins

International Journal of Peptide Research and Therapeutics

Volumn 12, Issue 3, 2006, Pages 269-273

  Hussain, Rohanah ^a   Joannou, Christopher L ^b   Siligardi, Giuliano ^a  

^a DIAMOND LIGHT SOURCE LTD   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antimicrobial; Cationic; Lipopeptides

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; PEPTIDE RH 01; PEPTIDE RH 02; POLYPEPTIDE ANTIBIOTIC AGENT; RH 01; RH 02; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ASPERGILLUS NIGER; BLOOD CLOT LYSIS; CANDIDA ALBICANS; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FATALITY; DRUG IDENTIFICATION; DRUG POTENCY; DRUG STABILITY; DRUG SYNTHESIS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; KLEBSIELLA AEROGENES; LIPOPHILICITY; MALE; MICROCOCCUS LUTEUS; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PHYSICAL CHEMISTRY; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; SALMONELLA ABONY; STAPHYLOCOCCUS AUREUS; TOXICITY TESTING;

ASPERGILLUS NIGER; BACTERIA (MICROORGANISMS); CANDIDA ALBICANS; FUNGI; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 33745818539     PISSN: 15733149     EISSN: 15733904     Source Type: Journal    
DOI: 10.1007/s10989-006-9033-4     Document Type: Conference Paper

References (17)

1. Barron, S.: 1996, Medical Microbiology (4th ed.). The University of Texas Medical Branch at Galveston, TX.
2. Bevins, C.: 1994, Ciba Foundation Symp. 186, 250-269.
3. Blasi, F., Braga, P., Cazzola, M., Cosentini, R. and Tarsia, P.: 2002, Expert Opin. Investig. Drugs 11(4), 545-552.
4. Brock, T. D.: 1974, Biology of Microorganisms (2nd ed.). Prentice-Hall, Englewood Cliffs NJ.
5. Chia, B. C. S., Lam, Y-H., Dyall-Smith, M., Separovic, F. and Bonie, J. H.: 2000, Lett. Pept. Sci 7, 151-156.
6. Chapple, D. S., Hussain, R., Joannou, C. L., Hancock, R. E., Odell, E., Evans, R. W. and Siligardi, G.: 2004, Antimicrob. Agents Chemother. 48(6), 2190-2198.
7. Edelman, A. M., Blumenthal, D. K. and Krebs, E. G.: 1987, Ann. Rev. Biochem. 56, 567-613.
8. Hancock, R. E. W. and Chapple, D. S.: 1999, Antimicrob. Agents Chemo. 43, 215-220.
9. Hancock, R. E. W. and Lehrer, R.: 1998, Trends Biotech. 16, 82-88.
10. Hancock, R. E. W. and Diamond, G.: 2000, Trends. Microbiol. 8, 402-410.
11. Hardie, G.: 1988, Nature 335, 592-593.
12. House, C. and Kemp, B. E.: 1987, Science 238, 1726-1728.
13. Hussain, R., Sergheraert, C., Drake, A. F. and Siligardi, G.: 1995, Biomed. Pept. Proteins Nucl. Acids 1(2), 69-72.
14. Schmidt, O., Rahmann, M. M., Ma, G., Theopold, U., Sun, Y., Sarjan, M., Fabbri, M. and Roberts, H.: 2005, Invertebrate Survival J. 2, 82-90.
15. Shai, Y.: 2002, Biopolymer (Peptide Science) 66, 236-248.
16. Papo, N. and Shai, Y.: 2003, Peptides 24, 1693-1703.
17. Zasloff, M.: 2002, N. Engl. J. Med. 347, 1199-1200.